Golden State Medical Supply Recalls Meclizine Hydrochloride Tablets Due to Impurities
Golden State Medical Supply Inc. is recalling 1,136 bottles of Meclizine Hydrochloride tablets because they failed impurity specifications.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class III, which indicates a low risk of adverse health consequences, and no specific injuries or illnesses are reported in the source text.
Plain-English summary
Golden State Medical Supply Inc. is recalling 1,136 bottles of Meclizine Hydrochloride Tablets, 12.5 mg, packaged in 1000-count bottles. The product is prescription-only and was distributed nationwide in the United States. The tablets were manufactured by Par Pharmaceuticals Companies Inc. and packaged by GSMS Incorporated.
The recall was initiated because the product failed impurities/degradation specifications, specifically being out of specification for impurities. The affected lots include GS007205, GS007344, GS008089, GS008842, GS009055, and GS009131, with expiration dates ranging from August 2017 to February 2018.
Consumers and healthcare providers should stop using the recalled product and contact their healthcare provider or pharmacist for guidance on replacement or disposal.
The recalled product
- Product
- MECLIZINE HYDROCHLORIDE TABLETS, 12.5 mg, Packaged in 1000 ct Bottles, Rx Only. Manufactured by: Par Pharmaceuticals Companies Inc., Spring Valley, NY 10977. Packaged by: GSMS Incorporated, Carmarillo, CA 93012. NDC: 60429-204-10.
- Manufacturer
- Golden State Medical Supply Inc.
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 1,136
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Lot # GS007205 Expiry: Aug-17
- Lot #:GS007344
- Expiry: Aug-17
- Lot #: GS008089
- Expiry: Feb-18
- Lot #: GS008842
- Lot #: GS009055
- Lot #: GS009131
- Expiry: Feb-18.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Golden State Medical Supply Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Golden State Medical Supply Inc.
See all →- SevereGolden State Medical Supply Recalls Prasugrel Tablets for Failed Dissolution
FDA (Drugs) · 2026-09-09
- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- ModerateNiacin extended-release tablets failed dissolution testing at 24 hours
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27
Same hazard · impurities
See all →- ModerateCipla Recalls Fosfomycin Tromethamine Due to Impurity Specification Failures
FDA (Drugs) · 2026-10-14
- LowSun Pharmaceutical Recalls Tretinoin Cream Due to Impurity Failures
FDA (Drugs) · 2026-10-14
- LowSun Pharmaceutical Recalls Tretinoin Cream Due to Impurity Failures
FDA (Drugs) · 2026-10-14
- LowSun Pharmaceutical Recalls Tretinoin Cream Due to Impurity Specifications
FDA (Drugs) · 2026-10-14
- LowMacleods Recalls Olanzapine Tablets Due to Impurity Levels
FDA (Drugs) · 2026-09-30
Similar recalls
- ModeratePar Pharmaceutical Recalls Meclizine Hydrochloride Tablets Due to Impurity Failures
FDA (Drugs) · 2015-11-25
- LowPar Pharmaceutical Recalls Meclizine Hydrochloride Tablets Due to Impurities
FDA (Drugs) · 2015-11-25
- ModerateMylan Recalls Meclizine Hydrochloride Tablets Due to Impurity Failures
FDA (Drugs) · 2015-11-25
- HighMeclizine hydrochloride 12.5 mg tablets recalled after failing tablet specifications
FDA (Drugs) · 2026-04-01
- ModerateParoxetine 40 mg tablets recalled for out-of-specification impurities
FDA (Drugs) · 2023-12-06
- ModerateWilshire Pharmaceuticals Recalls Meclizine HCl Tablets for Dissolution Failures
FDA (Drugs) · 2021-02-24